Ugur Sahin

Updated version of Covid-19 vaccine needed by middle of 2022 as new variants mutate, says BioNTech CEO - THE EDGE SINGAPORE

Covid-19

Updated version of Covid-19 vaccine needed by middle of 2022 as new variants mutate, says BioNTech CEO

"This virus will stay, and the virus will further adapt," says Sahin.
BioNTech to open regional HQ and vaccine manufacturing facility in Singapore - THE EDGE SINGAPORE

Company in the news

BioNTech to open regional HQ and vaccine manufacturing facility in Singapore

The German biotech company plans to make Singapore its regional hub for Southeast Asia.
Pfizer's Covid-19 vaccine prevents 90% of infections in study - THE EDGE SINGAPORE

Covid-19

Pfizer's Covid-19 vaccine prevents 90% of infections in study

The news added more than US$500 billion ($674.04 billion) to the value of the MSCI All Country World Index.
×